Divis Laboratories has reported results for the quarter and the year ended March 31, 2011
The company’s net profit for the fourth quarter surged by 34.41% at Rs 174.75 crore as compared to Rs 130.01 crore for the quarter ended March 31, 2010. Its total income has soared by 55.24% at Rs 490.05 crore for the quarter under review from Rs 315.67 crore in the corresponding previous quarter.
The company has registered a growth of 26.55% in its net profit for the year ended March 31, 2011 at Rs 435.57 crore as compared to Rs 344.20 crore for the year ended March 31, 2010. Its total income has increased by 40.00% at Rs 1344.04 crore for the year from Rs 959.98 crore in previous year.
On consolidated basis, the group’s net profit for the year has rose 26.13% at Rs 429.27 crore as compared to Rs 340.34 crore for the year ended March 31, 2010. Total income for the year has increased by 37.67% at 1343.60 crore as compared to Rs 975.95 crore for the previous year.
Divis Laboratories has recommended a dividend of 500% or Rs 10 per equity share of Rs 2 face value for the year ended March 31, 2011.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1857.60 |
Dr. Reddys Lab | 1399.10 |
Cipla | 1507.25 |
Lupin | 2355.95 |
Zydus Lifesciences | 1005.80 |
View more.. |